Exhaled nitric oxide is associated with inflammatory biomarkers and risk of acute respiratory exacerbations in children with HIV‐associated chronic lung disease

Author:

Flygel Trym Thune12,Hameiri‐Bowen Dan3,Simms Victoria4,Rowland‐Jones Sarah3,Ferrand Rashida Abbas56,Bandason Tsitsi6,Yindom Louis‐Marie3,Odland Jon Øyvind78,Cavanagh Jorunn Pauline12,Flægstad Trond12,Sovershaeva Evgeniya29

Affiliation:

1. Paediatric Research Group, Department of Clinical Medicine, Faculty of Health sciences UiT – The Arctic University of Norway Tromsø Norway

2. Department of Paediatrics University Hospital of North Norway Tromsø Norway

3. Nuffield Department of Medicine University of Oxford Oxford UK

4. Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health London School of Hygiene and Tropical Medicine London UK

5. Department of Clinical Research, Faculty of Infectious and Tropical Diseases London School of Hygiene and Tropical Medicine London UK

6. Biomedical Research and Training Institute Harare Zimbabwe

7. Department of Public Health and Nursing, Faculty of Medicine and Health Sciences NTNU The Norwegian University of Science and Technology Trondheim Norway

8. School of Health Systems and Public Health, Faculty of Health Sciences University of Pretoria Pretoria South Africa

9. Department of Microbiology and Infection Control Akershus University Hospital Nordbyhagen Norway

Abstract

AbstractObjectivesChronic lung disease is a recognized complication in children with HIV. Acute respiratory exacerbations (ARE) are common among this group and cause significant morbidity. Exhaled nitric oxide (eNO) is a known marker of local airway inflammation. We investigated the association between eNO and ARE, biomarkers of systemic inflammation, and the effect of azithromycin on eNO levels.MethodsIndividuals aged 6–19 years with HIV‐associated chronic lung disease in Harare, Zimbabwe, were enrolled in a placebo‐controlled randomized trial investigating the effect of 48‐week azithromycin treatment on lung function and ARE. eNO levels and biomarkers were measured at inclusion and after treatment in a consecutively enrolled subset of participants. Linear regression and generalized linear models were used to study associations between eNO and ARE, biomarkers, and the effect of azithromycin on eNO levels.ResultsIn total, 172 participants were included in this sub‐study, 86 from the placebo group and 86 from the azithromycin group. Participants experiencing at least one ARE during follow‐up had significantly higher eNO levels at baseline than participants who did not (geometric mean ratio 1.13, 95% confidence interval [CI] 1.03–1.24, p = 0.015), adjusted for trial arm, age, sex and history of tuberculosis. Matrix metalloproteinase (MMP)‐3, ‐7, and ‐10 were significantly associated with higher baseline eNO levels. At 48 weeks, azithromycin treatment did not affect eNO levels (geometric mean ratio 0.86, 95% CI 0.72–1.03, p = 0.103).ConclusionHigher baseline eNO levels were a risk factor for ARE. eNO was associated with proinflammatory biomarkers previously found to contribute to the development of chronic lung disease. The potential use of eNO as a marker of inflammation and risk factor for ARE in HIV‐associated chronic lung disease needs further investigation.

Funder

Norges Forskningsråd

Wellcome Trust

Medical Research Council

European Commission

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3